At least three companies including Sunac China (1918), Wuxi Biologics (Cayman) (2269), and Sunway will opt for share placements to raise more than HK$12 billion.
Sunac is to raise about HK$7 billion by placing shares at between HK$42.7 to HK$43.7, equivalent to a discount of about 7 percent to yesterday's closing price of HK$46.65. Sunac's share placement came when many mainland developers are issuing dollar-dominated debts in a tightening funding squeeze.
Shares of Sunway International (0058), which suspended trading from December 2, surged 65 percent to HK$0.132 after resuming trade yesterday.
Wealthy Port, wholly owned by Sunway International's executive director Oscar Chim Sai-yau, purchased 149 million shares of Sunway at HK$0.1, a premium of about 25 percent to the closing price of HK$0.08 on November 29, according to the company's filing to the stock exchange.
Also, Wuxi Biologics (Cayman) is to raise about HK$5.1 billion at between HK$95 to HK$97, a discount of about 7 percent to its closing price of HK$103.2.
In other news, two of China Evergrande Group's wealth-management affiliates - Evergrande Wealth Management and Chenyu Investment Management (Shenzhen) - have been warned by local authorities about fundraising without a license.
Sunac chairman Sun Hongbin. SING TAO
